|Articles|February 10, 2023
SCOPE 2023: Concerns With Clinical Technology
Author(s)Andy Studna, Senior Editor
Advertisement
In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Melissa Easy, VP and GM, clinical technologies at IQVIA dicusses how tehcnology and data can be used more effectively in supporting patients throughout clinical trials.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Patient Centricity: What Rare Disease Research Gets Right
2
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
3
ACT Brief: Hidden RBQM Value, Rare Disease Patient Partnership, and Safety Perception in IBD
4
The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness
5